The Leukemia Therapeutics Market is predicted to reach US$ by 2030 from US$ 13.95 billion in 2021, and to grow at a CAGR of 6.5% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Type (Acute Lymphocytic Leukemia (ALL), Acute myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Chronic Lymphocytic Leukemia (CLL)), Treatment Type (Targeted Drugs, Chemotherapy, and Immunotherapy), Mode of Administration (Injectable and Oral)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Novartis International AG, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Sanofi S.A, AbbVie Inc., Gilead Sciences, Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Amgen Inc., and Pfizer Inc. among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Leukemia Therapeutics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Leukemia Therapeutics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Leukemia Therapeutics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Leukemia Therapeutics - ANALYSIS & FORECAST, BY REGION
North America Leukemia Therapeutics
1. North America Leukemia Therapeutics , by Country
1. US
2. Canada
1. North America Leukemia Therapeutics , by Product
2. North America Leukemia Therapeutics , by Type
3. North America Leukemia Therapeutics , by Gender
4. North America Leukemia Therapeutics , by Sales Channel
3. Europe Leukemia Therapeutics
1. Europe Leukemia Therapeutics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Leukemia Therapeutics , by Product
3. Europe Leukemia Therapeutics , by Type
4. Europe Leukemia Therapeutics , by Gender
5. Europe Leukemia Therapeutics , by Sales Channel
4. Asia Pacific Leukemia Therapeutics
1. Asia Pacific Leukemia Therapeutics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Leukemia Therapeutics , by product
3. Asia Pacific Leukemia Therapeutics , by Type
4. Asia Pacific Leukemia Therapeutics , by Gender
5. Asia Pacific Leukemia Therapeutics , by Sales Channel
5. Rest of the World Leukemia Therapeutics
1. Rest of the World Leukemia Therapeutics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Leukemia Therapeutics , by Product
3. Rest of the World Leukemia Therapeutics , by Type
4. Rest of the World Leukemia Therapeutics , by Gender
5. Rest of the World Leukemia Therapeutics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 37
Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market:
The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...
Overview of the Global Antibody Based Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Antibody Based Therapeutics Market during the forecast period 2023-2030. ...
Overview of the Global Office-Based Sleep Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Office-Based Sleep Therapeutics Market during the forecast period 202...
Overview of the Global Digital Therapeutics Navigation Platform Market:
The report discusses everything a marketer requires before investing in the global Digital Therapeutics Navigation Platform Market during the f...
Overview of the Global Substance Abuse Disorder Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Substance Abuse Disorder Therapeutics Market during the forecas...
Overview of the Global Patient-Specific Cancer Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Patient-Specific Cancer Therapeutics Market during the forecast ...
Description
The Nucleic Acid Based Therapeutics Market is poised for significant growth, with a projected expansion from USD 4.28 billion in 2022 to USD 9.51 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 11.6% during the forecast period of 2023-2029. This market pr...
Executive Summary
Azoth Analytics has released a research report titled "Global Branded PAH Therapeutics Market (2023 Edition)" which provides a complete analysis of the Global Branded PAH Therapeutics industry in terms of market segmentation By Drug Class (Endothelin Receptor Antagonis...
Overview of the Global Women's Healthcare Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Women's Healthcare Therapeutics Market during the forecast period 202...
Overview of the Global Mrna Therapeutics Process Development Market:
The report discusses everything a marketer requires before investing in the global Mrna Therapeutics Process Development Market during the forecas...